{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:33:12Z","timestamp":1711542792052},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.remn.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T07:15:42Z","timestamp":1498029342000},"page":"3-8","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concordancia entre la PET cerebral con 18 F-FDG y los biomarcadores en l\u00edquido cefalorraqu\u00eddeo en el diagn\u00f3stico de enfermedad de Alzheimer"],"prefix":"10.1016","volume":"37","author":[{"given":"S.","family":"Rub\u00ed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Noguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tarong\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Oporto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Vico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Espino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Picado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2017.05.003_bib0145","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.remn.2017.05.003_bib0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.remn.2017.05.003_bib0155","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.remn.2017.05.003_bib0160","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.remn.2017.05.003_bib0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2967\/jnumed.111.096578","article-title":"Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: A review of the recent literature","volume":"53","author":"Bohnen","year":"2012","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2017.05.003_bib0170","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.remn.2017.05.003_bib0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-150953","article-title":"Diagnostic impact of cerebrospinal fluid biomarker (Pre-)analytical variability in Alzheimer's disease","volume":"51","author":"Niemantsverdriet","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.remn.2017.05.003_bib0180","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/clinchem\/47.10.1776","article-title":"Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values","volume":"47","author":"Sj\u00f6gren","year":"2001","journal-title":"Clin Chem."},{"key":"10.1016\/j.remn.2017.05.003_bib0185","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jalz.2014.03.003","article-title":"The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative","volume":"10","author":"Molinuevo","year":"2014","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.remn.2017.05.003_bib0190","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann Neurol."},{"key":"10.1016\/j.remn.2017.05.003_bib0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology \u2014 concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.remn.2017.05.003_bib0200","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jamaneurol.2016.2237","article-title":"Heterogeneity in suspected non\u2013Alzheimer disease pathophysiology among clinically normal older individuals","volume":"2129","author":"Mormino","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.remn.2017.05.003_bib0205","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/jamaneurol.2016.2842","article-title":"Cause of suspected non\u2013Alzheimer disease pathophysiology: If not tau pathology, then what?","volume":"73","author":"Villeneuve","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.remn.2017.05.003_bib0210","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jamaneurol.2016.2843","article-title":"Brain atrophy on magnetic resonance imaging as a biomarker of neurodegeneration","volume":"73","author":"Jack","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.remn.2017.05.003_bib0215","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jnen\/nlw033","article-title":"New old pathologies: AD, PART, and cerebral age-related TDP-43 with sclerosis (CARTS)","volume":"75","author":"Nelson","year":"2016","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.remn.2017.05.003_bib0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156720512799361592","article-title":"Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease","volume":"9","author":"Yakushev","year":"2012","journal-title":"Curr Alzheimer Res."},{"key":"10.1016\/j.remn.2017.05.003_bib0225","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jalz.2014.03.006","article-title":"Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease","volume":"10","author":"Alexopoulos","year":"2014","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.remn.2017.05.003_bib0230","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","article-title":"Relationships between biomarkers in aging and dementia","volume":"73","author":"Jagust","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.remn.2017.05.003_bib0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brainresbull.2008.01.010","article-title":"CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease","volume":"76","author":"Ceravolo","year":"2008","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.remn.2017.05.003_bib0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MNM.0000000000000272","article-title":"Functional correlates of t-Tau, p-Tau and A\u03b21-42amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET\/CT study","volume":"36","author":"Chiaravalloti","year":"2015","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.remn.2017.05.003_bib0245","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s00259-009-1063-7","article-title":"Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease","volume":"36","author":"Arlt","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2017.05.003_bib0250","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1373\/clinchem.2009.130518","article-title":"Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease","volume":"56","author":"Mulder","year":"2010","journal-title":"Clin Chem."},{"key":"10.1016\/j.remn.2017.05.003_bib0255","first-page":"1920","article-title":"FDG PET imaging in patients with pathologically verified dementia","volume":"41","author":"Hoffman","year":"2000","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remn.2017.05.003_bib0260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","article-title":"Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative","volume":"8","author":"Vanderstichele","year":"2012","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.remn.2017.05.003_bib0265","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3233\/JAD-151097","article-title":"A decade of cerebrospinal fluid biomarkers for Alzheimer's disease in Belgium","volume":"54","author":"Somers","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.remn.2017.05.003_bib0270","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00004424-199606000-00002","article-title":"Interpretation variability of 18FDG-positron emission tomography studies in dementia","volume":"31","author":"Hoffman","year":"1996","journal-title":"Invest Radiol."},{"key":"10.1016\/j.remn.2017.05.003_bib0275","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12149-014-0932-8","article-title":"Measurement of inter- and intra-observer variability in the routine clinical interpretation of brain 18-FDG PET-CT","volume":"29","author":"Brucher","year":"2015","journal-title":"Ann Nucl Med."},{"key":"10.1016\/j.remn.2017.05.003_bib0280","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010","volume":"71","author":"Beach","year":"2012","journal-title":"J Neuropathol Exp Neurol."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16302372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16302372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T15:23:16Z","timestamp":1602343396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X16302372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2253654X16302372"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2017.05.003","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concordancia entre la PET cerebral con 18F-FDG y los biomarcadores en l\u00edquido cefalorraqu\u00eddeo en el diagn\u00f3stico de enfermedad de Alzheimer","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}